Despite significant improvements in reperfusion strategies, acute coronary syndromes all too
often culminate in a myocardial infarction (MI). The consequent MI can, in turn, lead to …

Heart failure (HF) describes a heterogenous complex spectrum of pathological conditions
that results in structural and functional remodeling leading to subsequent impairment of …

The increasing use of single-cell immune profiling and advanced microscopic imaging
technologies has deepened our understanding of the cardiac immune system, confirming …

Approximately 7 million people are affected by acute myocardial infarction (MI) each year,
and despite significant therapeutic and diagnostic advancements, MI remains a leading …

Inflammation, fibrosis and metabolic stress critically promote heart failure with preserved
ejection fraction (HFpEF). Exposure to high-fat diet and nitric oxide synthase inhibitor N [w] …

Large animal models of cardiac ischemia-reperfusion are critical for evaluation of the
efficacy of cardioprotective interventions prior to clinical translation. Nonetheless, current …

Although anti-inflammatory drugs have shown promising results in preclinical cardiovascular
research, they have yielded little benefit in clinical trials. Before we can expect positive …

Echocardiography is a non-invasive imaging technique providing real-time information to
assess the structure and function of the heart. Due to advancements in technology, ultra …

Inflammation, fibrosis and metabolic stress critically promote heart failure with preserved
ejection fraction (HFpEF). Exposure to high-fat diet and nitric oxide synthase inhibitor N [w] …

Myocardial infarction (MI) continues to be a leading cause of death worldwide. Even though
it is well-established that the complex interplay between different cell types determines the …